clock menu more-arrow no yes
cells at desk image

Can cell & gene therapy teach a cell to save a life?

Researchers are reprogramming cells at the genetic level to treat disease—and changing the landscape of modern medicine in the process.

This advertising content was produced in collaboration between Vox Creative and our sponsor, without involvement from Vox Media editorial staff.

As unique individuals, we gravitate toward the idea of treatment that’s tailored to the patient. Cell and gene therapy represents a major leap in personalized medicine and a turning point in our ability to treat and potentially even cure many serious illnesses. Each therapy is designed based on detailed information about the roots of a patient’s disease. It treats a condition at its source, repairing or enhancing cells at the genetic level. Novartis is a global healthcare company that’s collaborating to develop cell and gene therapies for a variety of diseases, including certain genetic disorders and cancers.


Learn more about how Novartis is reimagining medicine here.

CRISPR for Breakfast

CRISPR for Breakfast
Sometimes, medical breakthroughs have surprising beginnings. When scientists first observed unusual repeating DNA patterns in bacteria, they had little idea what they were seeing. Listen below.


How Viruses Help Treat Disease

The Flip Side
In medicine, as in life, there’s always more than one side to the story. Take viruses. Yes, they can infiltrate our bodies and make us sick. But some of them can actually be — heroic. Listen below.




Cell and Gene Therapy
Welcome to Cell & Gene Academy
Can we teach a cell to save a life? Researchers are reprogramming cells at the genetic level to treat disease—and changing the landscape of modern medicine in the process.




Fixing The Foundation
Fixing The Foundation
In some ways, the human body is like a house. And when there’s an issue with the original blueprint, disease can result. What if we could treat the root cause of the problem?


Advertiser Content From Novartis  logo